tiprankstipranks
Trending News
More News >
Flowserve (FLS)
NYSE:FLS

Flowserve (FLS) AI Stock Analysis

Compare
450 Followers

Top Page

FLS

Flowserve

(NYSE:FLS)

Select Model
Select Model
Select Model
Outperform 79 (OpenAI - 4o)
Rating:79Outperform
Price Target:
$82.00
▲(14.30% Upside)
Flowserve's strong financial performance and strategic initiatives, such as the divestiture of asbestos liabilities, are significant positives. The company's robust earnings call and positive technical indicators further support the stock's outlook. However, valuation concerns and potential challenges in certain market segments slightly temper the overall score.
Positive Factors
Revenue Growth
Flowserve's robust revenue growth indicates strong market demand and effective sales strategies, positioning the company for sustained expansion.
Cash Flow Generation
Strong cash flow generation enhances Flowserve's ability to invest in growth opportunities and maintain financial flexibility, supporting long-term stability.
Asbestos Liabilities Divestiture
Divesting asbestos liabilities reduces financial risk and volatility, allowing Flowserve to focus on growth and improve cash flow predictability.
Negative Factors
Challenges in Engineered Pump Projects
Declines in engineered pump project bookings could impact future revenue streams and indicate potential challenges in project execution.
Weakness in Chemical End Market
Weakness in the chemical market suggests limited growth opportunities in this segment, potentially affecting Flowserve's overall market expansion.
Middle East Energy Project Slowdown
A slowdown in Middle East energy projects may hinder growth in a key market, impacting Flowserve's revenue and strategic objectives.

Flowserve (FLS) vs. SPDR S&P 500 ETF (SPY)

Flowserve Business Overview & Revenue Model

Company DescriptionFlowserve Corporation designs, develops, manufactures, distributes, and services industrial flow management equipment in the United States, Europe, the Middle East, Africa, Asia, and internationally. It operates in two segments, Flowserve Pump Division (FPD) and Flow Control Division (FCD). The FPD segment offers custom and pre-configured pumps and pump systems, mechanical seals, auxiliary systems, replacement parts, upgrades, and related aftermarket services, including installation and commissioning services, seal systems spare parts, repairs, advanced diagnostics, re-rate and upgrade solutions, retrofit programs, and machining and asset management solutions, as well as manufactures a gas-lubricated mechanical seal for use in high-speed compressors for gas pipelines. The FCD segment provides engineered and industrial valve and automation solutions, including isolation and control valves, actuation, controls, and related equipment, as well as equipment maintenance services for flow control systems, including advanced diagnostics, repair, installation, commissioning, retrofit programs, and field machining capabilities. This segment's products are used to control, direct, and manage the flow of liquids, gases, and fluids. The company primarily serves oil and gas, chemical and pharmaceuticals, power generation, and water management markets, as well as general industries, including mining and ore processing, pulp and paper, food and beverage, and other smaller applications. The company distributes its products through direct sales, distributors, and sales representatives. Flowserve Corporation was incorporated in 1912 and is headquartered in Irving, Texas.
How the Company Makes MoneyFlowserve generates revenue through the sale of its extensive range of products and services, which include engineered pumps, valves, seals, and aftermarket services. The company's revenue model is built on both product sales and service contracts, with significant earnings derived from the installation, maintenance, and repair of its products. Key revenue streams include the manufacturing and distribution of fluid motion and control solutions, as well as long-term service agreements that ensure ongoing support and maintenance for customers. Flowserve has established partnerships with major players in the energy and industrial sectors, which further contribute to its revenue through collaborative projects and joint ventures. Additionally, the company benefits from a strong global presence, allowing it to tap into various regional markets and capitalize on growing demand for energy-efficient and reliable fluid management solutions.

Flowserve Earnings Call Summary

Earnings Call Date:Oct 28, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 24, 2026
Earnings Call Sentiment Positive
Flowserve delivered strong financial performance with significant growth in aftermarket and nuclear segments. The company successfully increased its guidance and achieved margin expansion, with strategic moves like the divestment of asbestos liabilities enhancing future cash flow. However, challenges in engineered pump projects, the chemical market, and a slowdown in Middle East energy projects present areas of concern.
Q3-2025 Updates
Positive Updates
Exceptional Financial Performance
Flowserve delivered exceptional results across bookings, margin expansion, earnings, and cash flow. Adjusted EPS guidance increased to $3.40 to $3.50, representing a 31% increase from last year and over 60% increase from 2023. Adjusted gross margins increased by 240 basis points to 34.8%, and adjusted operating margins were 14.8%.
Strong Aftermarket Growth
Aftermarket bookings exceeded $600 million for the sixth consecutive quarter, with some quarters seeing bookings above $650 million. This segment continues to deliver strong performance and growth opportunities.
Nuclear Segment Success
Flowserve achieved over $140 million in nuclear bookings, marking a record for the company. The company is well-positioned in the nuclear space with content in over 75% of the world's approximately 400 nuclear reactors.
Mogas Integration and Performance
The Mogas acquisition contributed to a 3% growth in revenue, with operating margins for Mogas being accretive to FCD. The integration and implementation of the Flowserve Business System are yielding positive results.
Legacy Asbestos Liabilities Divestment
Flowserve reached an agreement to divest its legacy asbestos liabilities, simplifying its capital structure and reducing volatility. This transaction is expected to improve annual cash flow by $15 million to $20 million.
Negative Updates
Challenges in Engineered Pump Projects
There was a decline in bookings for engineered pump projects due to project timing and some year-over-year timing of project awards. This impacted the overall bookings growth.
Weakness in Chemical End Market
The chemical segment remained the lowest growth end market, although there was some improvement in North America.
Middle East Energy Project Slowdown
Bookings in the Middle East energy projects were at a five-year low, which impacted growth in the energy segment.
Company Guidance
In the third quarter of 2025, Flowserve showed strong performance metrics across various areas. The company increased its adjusted EPS guidance range to $3.40 to $3.50, representing a 31% increase from the prior year and over 60% from 2023. Bookings for the quarter reached $1.2 billion, with revenue growth of 4%. Adjusted gross margins improved by 240 basis points to 34.8%, while adjusted operating margins increased to 14.8%. The quarter's adjusted EPS was $0.90, reflecting a 45% rise from the previous year. Flowserve returned $173 million to shareholders, including $145 million in share repurchases, and reported significant cash flow performance, with $402 million in cash from operations. The company also highlighted a $10 billion opportunity in the nuclear flow control sector over the next decade, leveraging its strong market position and expertise in the industry.

Flowserve Financial Statement Overview

Summary
Flowserve exhibits strong financial health with impressive revenue growth, improved profitability, and a solid balance sheet. The company's cash flow generation is robust, supporting its operational and strategic initiatives. While the company has reduced its leverage significantly, maintaining this trajectory will be crucial for sustaining long-term growth.
Income Statement
Flowserve has demonstrated strong revenue growth, with a TTM revenue growth rate of 89%. The company has improved its profitability margins, with a gross profit margin of 32.8% and a net profit margin of 9.8% in the TTM period. EBIT and EBITDA margins have also shown positive trends, indicating efficient cost management and operational performance.
Balance Sheet
The balance sheet reflects a solid financial position with a low debt-to-equity ratio of 0.10 in the TTM period, indicating reduced leverage. Return on equity has improved to 21.3%, showcasing effective utilization of equity. The equity ratio stands at 38.8%, suggesting a stable capital structure.
Cash Flow
Cash flow performance is robust, with a significant free cash flow growth rate of 57.66% in the TTM period. The operating cash flow to net income ratio is 1.55, indicating strong cash generation relative to net income. The free cash flow to net income ratio of 0.89 further supports the company's ability to generate cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.69B4.56B4.32B3.62B3.54B3.73B
Gross Profit1.58B1.47B1.30B994.65M1.07B1.16B
EBITDA797.96M541.05M374.42M291.58M291.03M359.23M
Net Income452.78M282.76M186.74M188.69M125.95M130.42M
Balance Sheet
Total Assets5.83B5.50B5.11B4.79B4.75B5.31B
Cash, Cash Equivalents and Short-Term Investments833.85M675.44M545.68M434.97M658.45M1.10B
Total Debt1.67B1.69B1.40B1.46B1.50B1.94B
Total Liabilities3.51B3.45B3.13B2.93B2.91B3.55B
Stockholders Equity2.26B2.01B1.94B1.82B1.80B1.73B
Cash Flow
Free Cash Flow629.02M344.29M258.41M-116.30M195.18M253.13M
Operating Cash Flow703.41M425.31M325.77M-40.01M250.12M310.54M
Investing Cash Flow-377.57M-387.21M-68.58M-6.09M-59.48M-41.70M
Financing Cash Flow-106.07M117.50M-153.01M-150.01M-599.71M147.59M

Flowserve Technical Analysis

Technical Analysis Sentiment
Positive
Last Price71.74
Price Trends
50DMA
69.62
Positive
100DMA
61.47
Positive
200DMA
55.23
Positive
Market Momentum
MACD
0.83
Positive
RSI
56.46
Neutral
STOCH
66.82
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FLS, the sentiment is Positive. The current price of 71.74 is above the 20-day moving average (MA) of 71.15, above the 50-day MA of 69.62, and above the 200-day MA of 55.23, indicating a bullish trend. The MACD of 0.83 indicates Positive momentum. The RSI at 56.46 is Neutral, neither overbought nor oversold. The STOCH value of 66.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FLS.

Flowserve Risk Analysis

Flowserve disclosed 29 risk factors in its most recent earnings report. Flowserve reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Flowserve Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$9.13B20.8720.97%1.17%3.19%69.89%
79
Outperform
$27.35B12.4215.88%1.04%-5.24%45.69%
77
Outperform
$10.37B44.2512.76%12.60%24.02%
75
Outperform
$16.37B26.1517.97%0.96%0.83%-1.32%
72
Outperform
$15.31B29.9417.85%0.79%8.01%2.67%
69
Neutral
$9.99B39.903.89%0.97%-4.99%22.16%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FLS
Flowserve
71.74
14.35
25.00%
DOV
Dover
201.99
20.39
11.23%
ITT
ITT
180.20
42.35
30.72%
PNR
Pentair
103.06
7.07
7.37%
RRX
Regal Rexnord
154.27
6.20
4.19%
SPXC
SPX
207.44
69.38
50.25%

Flowserve Corporate Events

Executive/Board Changes
Flowserve Announces Planned Board Transition as Director Departs
Neutral
Dec 30, 2025

On December 29, 2025, Flowserve Corporation announced that director Kenneth I. Siegel informed the board he will not stand for re-election at the company’s 2026 annual meeting of shareholders and will continue to serve as a director until that meeting. The company said Siegel’s decision was not due to any disagreement with management or the board, and the directors expressed their appreciation for his service and contributions, signaling an orderly and non-contentious board transition for stakeholders.

The most recent analyst rating on (FLS) stock is a Hold with a $80.00 price target. To see the full list of analyst forecasts on Flowserve stock, see the FLS Stock Forecast page.

Financial DisclosuresM&A Transactions
Flowserve Completes Divestiture of Asbestos Liabilities
Negative
Dec 11, 2025

On December 11, 2025, Flowserve Corporation completed the divestiture of its legacy asbestos liabilities by selling its subsidiary BW/IP – New Mexico, Inc. to Ajax HoldCo LLC, an affiliate of Acorn Investment Partners. This transaction, which involved a total capitalization of approximately $219 million, allows Flowserve to remove these liabilities from its balance sheet and indemnifies the company from future financial exposure related to these liabilities. As a result, Flowserve expects a one-time loss of approximately $140 million in the fourth quarter of 2025, which will be excluded from adjusted earnings per share.

The most recent analyst rating on (FLS) stock is a Buy with a $85.00 price target. To see the full list of analyst forecasts on Flowserve stock, see the FLS Stock Forecast page.

Business Operations and StrategyM&A Transactions
Flowserve Divests Asbestos Liabilities to Ajax HoldCo
Positive
Oct 28, 2025

On October 28, 2025, Flowserve Corporation announced its decision to divest its legacy asbestos liabilities by selling the associated company to Ajax HoldCo LLC, an affiliate of Acorn Investment Partners. This strategic move is expected to provide greater financial certainty for investors and allow Flowserve to focus on growth and value-enhancing opportunities. The divestiture is anticipated to close in the fourth quarter of 2025, with Flowserve contributing $199 million and the buyer contributing $20 million to capitalize the company. This transaction will remove the asbestos liabilities and related insurance assets from Flowserve’s balance sheet, enabling the company to concentrate on organic and inorganic investments to expand its market reach.

The most recent analyst rating on (FLS) stock is a Buy with a $59.00 price target. To see the full list of analyst forecasts on Flowserve stock, see the FLS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 12, 2025